Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/30/2003WO2003088942A1 Cosmetic composition and method of treating skin and hair
10/30/2003WO2003088929A1 Method of treating onychomycosis with urea and an antioxidant
10/30/2003WO2003088927A2 Novel curcumin analogues and uses thereof
10/30/2003WO2003088920A2 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics
10/30/2003WO2003088918A2 PHARMACEUTICAL COMPOSITIONS CONTAINING α3β4 NICOTINIC RECEPTOR ANTAGONISTS AND METHODS OF THEIR USE
10/30/2003WO2003088915A2 Novel sodium channel blockers
10/30/2003WO2003088909A2 Methods for modulating phototoxicity
10/30/2003WO2003088908A2 Heterocyclo inhibitors of potassium channel function
10/30/2003WO2003088906A2 Methods of simultaneously treating ocular rosacea and acne rosacea
10/30/2003WO2003088905A2 Compositions and minimally invasive methods for treating incomplete tissue repair
10/30/2003WO2003088903A2 Compounds, compositions, and methods
10/30/2003WO2003088901A2 Oral rehydration composition
10/30/2003WO2003088900A2 Solid forms of salts with tyrosine kinase activity
10/30/2003WO2003088894A2 A multi component controlled release system for anhydrous cosmetic compositions
10/30/2003WO2003088880A2 Condom
10/30/2003WO2003088812A2 Nor-1 and nur77 nuclear receptors as targets for anti-leukemia therapy
10/30/2003WO2003088765A2 Functional foods containing a phospholipid-containing stable matrix
10/30/2003WO2003088761A2 Physiologically compatible, phospholipid-containing, stable and hard matrix
10/30/2003WO2003088749A1 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
10/30/2003WO2003088748A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003WO2003066629A3 Heteroaryl compounds useful as inhibitors of gsk-3
10/30/2003WO2003066579A3 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
10/30/2003WO2003065881A3 Medical device with coating that promotes endothelial cell adherence and differentiation
10/30/2003WO2003063796A3 Heterocyclic arylsulfonamidobenzylic compounds
10/30/2003WO2003059334A3 Gemcitabine in the treatment of smallpox
10/30/2003WO2003057072A3 Hemostatic compositions and methods for controlling bleeding
10/30/2003WO2003054161A3 USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
10/30/2003WO2003053365A3 Syn3 compositions and methods
10/30/2003WO2003053353A3 Administration of vasopeptidase inhibitors to reduce pulse pressure
10/30/2003WO2003053330A3 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer’s disease and conditions associated with glycogen synthase kinase-3
10/30/2003WO2003052095A3 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell
10/30/2003WO2003051833A3 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
10/30/2003WO2003051831A3 Protease inhibitors of the coagulation cascade isolated from dysidea sponges
10/30/2003WO2003051388A3 Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
10/30/2003WO2003051294A3 Mitocidal compositions and methods
10/30/2003WO2003051293A3 Antidiabetic formulation and method
10/30/2003WO2003051277A3 Novel compounds
10/30/2003WO2003049680A3 Compositions containing both sedative and non-sedative antihistamines
10/30/2003WO2003049674A3 Method for treatment of enveloped viruses using jojoba oil esters
10/30/2003WO2003049552A3 Beverage treated with nicotine
10/30/2003WO2003048148A3 Statin-like compounds
10/30/2003WO2003047697A3 Use of an farsenyl protein tranferase inhibitor in combination with other antineoplastic agents for the manufacture of a medicament against cancer
10/30/2003WO2003047529A3 Extended release pharmaceutical tablet of metformin
10/30/2003WO2003047508A3 Paclitaxel solvates
10/30/2003WO2003045319A3 Targeted therapeutics and uses thereof
10/30/2003WO2003043577A3 Modulators of rho c activity
10/30/2003WO2003043569A3 Trans-10, cis-12 conjugated linoleic acid isomer for the treatment of diseases
10/30/2003WO2003039545A3 Carboline derivatives as inhibitors of ikb in the treatment of multiple myeloma and others cancers
10/30/2003WO2003038032A3 Means for inhibition of the synthesis of viral proteins
10/30/2003WO2003037274A3 Pyrazole-amides and-sulfonamides
10/30/2003WO2003037246A3 Compositions and methods for prostate and kidney health and disorders, an herbal preparation
10/30/2003WO2003034903A3 Psma antibodies and protein multimers
10/30/2003WO2003033703A3 Human gtp-activator protein for rab-like gtpase
10/30/2003WO2003032921A3 Treatment of neurodegenerative diseases and cancer of the brain
10/30/2003WO2003032899A3 Methods and materials for targeting and affecting selected cells
10/30/2003WO2003029428A3 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease
10/30/2003WO2003029264A3 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
10/30/2003WO2003028527A3 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
10/30/2003WO2003027143A3 Gene and protein relating to hepatocellular carcinoma
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2003024455A3 Stent coated with a sustained-release drug delivery and method for use thereof
10/30/2003WO2003024436A3 Method for treating skin disorders
10/30/2003WO2003020309A3 Compound
10/30/2003WO2003020287A3 Methods for the treatment of chronic pain anc compositions therefor
10/30/2003WO2003018836A3 Model of autoimmune disease and methods for identifying agents against autoimmune disease
10/30/2003WO2003015608A3 Combination therapy for the treatment of cancer
10/30/2003WO2003013610A3 Surfactant compounds and uses thereof
10/30/2003WO2003013441A3 Levothyroxine compositions and methods
10/30/2003WO2003012051A3 Inhibitor of dna methylation
10/30/2003WO2003011881A3 Sugar derivatives of hydromorphone, dihydromorphine and dihydroisomorphine, compositions thereof and uses for treating or preventing pain
10/30/2003WO2003011299A3 Treatment of ocular hypertension and glaucoma
10/30/2003WO2003011271A3 Methods and compositions for modulating brain damage
10/30/2003WO2003004501A3 (hetero) aryl substituted benzofurans as 5-ht ligands
10/30/2003WO2003000717A3 Identification of ses-3 (spr-5) in c. elegans and the uses of the same
10/30/2003WO2002103042A3 Method and nucleic acids for the differentiation of prostate tumors
10/30/2003WO2002102777A8 NOVEL CRYSTALLINE FORMS OF 4-[4-[4-(HYDROXYDIPHENYLMETHYL)-1-PIPERINDINYL]-1-HYDROXYBUTYL]-α, α-DIMETHYLBENZENE ACETIC ACID AND ITS HYDROCHLORIDE
10/30/2003WO2002102229A3 Diagnosing tumorigenicity and determining resistance to anticancer therapy
10/30/2003WO2002100389A3 Compressible guaifenesin compositions and method for producing them
10/30/2003WO2002099041A3 Ces2s as modifiers of the p53 pathway and methods of use
10/30/2003WO2002098391A3 Process for preparing granular compositions
10/30/2003WO2002087563A3 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
10/30/2003WO2002085458A3 Use of nk-1 receptor antagonists against benign prostatic hyperplasia
10/30/2003WO2002085340A3 Oligonucleotide compositions and their use to induce differentiation of cells
10/30/2003WO2002084294A3 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/30/2003WO2002080978A3 Pharmaceutical compositions comprising ascomycin
10/30/2003WO2002072106A3 Combined method for treating hormono-dependent disorders with exemestane
10/30/2003WO2002069961A8 Il-8 receptor ligands-drugs for inflammatory and autoimmune diseases
10/30/2003WO2002069901A3 Cathepsin cysteine protease inhibitors
10/30/2003WO2002068617A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/30/2003WO2002066476A9 6-phenylbenzonaphthyridines
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003WO2002060406A8 Veterinary dermatologic composition
10/30/2003WO2002060405A8 Veterinary dermatologic composition comprising a sphingoid base and/or a sphingoid base derivative
10/30/2003WO2002060276A8 Combination of probiotics
10/30/2003WO2002056903A3 Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
10/30/2003WO2002053146A3 Matrix metalloproteinase inhibitors
10/30/2003WO2002043668A3 Antimycobacterial compounds and method for making the same
10/30/2003WO2002042303A3 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
10/30/2003WO2002027023A9 Genetic determinants for dermal inflammation and immunity
10/30/2003WO2002022819A3 Calcium binding proteins
1 ... 5291 5292 5293 5294 5295 5296 5297 5298 5299 5300 5301 5302 5303 5304 5305 5306 5307 5308 5309 5310 5311 ... 7860